Past, present, and future perspectives of ultrasound-guided ablation of liver tumors: Where could artificial intelligence lead interventional oncology?

doi:10.35713/aic.v5.i1.96690

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3061)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-8) series.

Item

Count

PDF

142

HTML

1969

Figures (1-8)

183

Sum=2294

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

208

Download

278

Sum=486

Publishing Process of This Article

Item

Count

Browse

Download

149

Sum=223

Jul 18, 2024 (publication date) through Mar 10, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

Artificial Intelligence in Cancer

ISSN

2644-3228

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

Artif Intell Cancer. Jul 18, 2024; 5(1): 96690
Published online Jul 18, 2024. doi: 10.35713/aic.v5.i1.96690

Full Size Figure Download Figure

Figure 8 Three-dimensional reconstruction of the ablation result showed the necrotic volume (deep green), planned safety margin (yellow), completely necrotic lesion (light green), and planned safety margin outside of necrosis volume (red).

Citation: Tombesi P, Cutini A, Grasso V, Di Vece F, Politti U, Capatti E, Labb F, Petaccia S, Sartori S. Past, present, and future perspectives of ultrasound-guided ablation of liver tumors: Where could artificial intelligence lead interventional oncology? Artif Intell Cancer 2024; 5(1): 96690
URL: https://www.wjgnet.com/2644-3228/full/v5/i1/96690.htm
DOI: https://dx.doi.org/10.35713/aic.v5.i1.96690